Svend Andersen

Svend Andersen

Directeur Général chez OMEGA PHARMA
64 ans
Health Technology
Consumer Services
Health Services

Profil

Svend D.
Andersen
is currently Director at Perrigo Europe Invest NV since 2019 and Managing Director & Director at Perrigo Holding NV since 2019.
Former positions include Director at Fertin Pharma A, Vice President & General Manager-EMEA at Zoetis Products LLC, President-EMEA & Vice President at Hospira, Inc. from 2010 to 2015, Vice President-Commercial Operations at Ferrosan ApS, Executive Vice President-Europe Region at LEO Pharma A from 2015 to 2016, Executive Vice President-Western Europe Sales at Actavis, Inc., Executive Vice President-Europe at LEO Laboratories Ltd. (Ireland), and EVP & President-Consumer Selfcare International at Perrigo Co. Plc from 2017 to 2024.
Education includes undergraduate studies at Copenhagen Business School.

Postes actifs de Svend Andersen

SociétésPosteDébut
OMEGA PHARMA Directeur Général 23/09/2019
Directeur/Membre du Conseil 14/11/2019

Anciens postes connus de Svend Andersen

SociétésPosteFin
PERRIGO COMPANY PLC Corporate Officer/Principal 31/07/2024
Corporate Officer/Principal 01/04/2016
HOSPIRA, INC. Corporate Officer/Principal 01/09/2015
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Voir l'expérience en détail de Svend Andersen

Formation de Svend Andersen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

57

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Svend Andersen